US Genetic Counseling Market

ID: MRFR/LS/50943-HCR 200 Pages Vikita Thakur Last Updated: September 17, 2026
US Genetic Counseling Market Research Report: By Counseling Approach (Integrated, Independent, Discretionary Genetic Counseling), By Key Players Business Model (Core Genetic Counseling Companies, Direct-to-Consumer Genetic Testing Companies, Clinical Genetic Testing Companies), By Channel (Providers, Self-Referred Individuals), By Type of Service (Risk Assessment, Pharmacogenomics, Other Genetic Pediatric Care Counseling Services), By Application (Proactive Risk Assessment, GC For Intent-to-Treat Patients (ITT), Prenatal and Preconception Care, Other), By Target Population Segment (General Population, Patient Population) and By Level of Service (Pre-counseling Support, Post Counseling Support) - Growth & Industry Forecast 2025 To 2035.
US Genetic Counseling Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)14.41%
2024 Market Size$ 420.79 Million
2025 Market Size$ 481.43 Million
2035 Market Size$ 1,850 Million
Key Players
Myriad Genetics
Invitae Corporation
Ambry Genetics
GeneDx
Fulgent Genetics
23andMe
Opportunities
  • Rising Awareness of Genetic Disorders
  • Increased Focus on Preventive Healthcare
  • Legislative Support for Genetic Services
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Industrial Automation & Equipment, BY Counseling Approach (USD Million)
      1. 4.1.1 Integrated
      2. 4.1.2 Independent
      3. 4.1.3 Discretionary Genetic Counseling
    2. 4.2 Industrial Automation & Equipment, BY Key Players Business Model (USD Million)
      1. 4.2.1 Core Genetic Counseling Companies
      2. 4.2.2 Direct-to-Consumer Genetic Testing Companies
      3. 4.2.3 Clinical Genetic Testing Companies
    3. 4.3 Industrial Automation & Equipment, BY Channel (USD Million)
      1. 4.3.1 Providers
      2. 4.3.2 Self-Referred Individuals
    4. 4.4 Industrial Automation & Equipment, BY Type of Service (USD Million)
      1. 4.4.1 Risk Assessment
      2. 4.4.2 Pharmacogenomics
      3. 4.4.3 Other Genetic Pediatric Care Counseling Services
    5. 4.5 Industrial Automation & Equipment, BY Application (USD Million)
      1. 4.5.1 Proactive Risk Assessment
      2. 4.5.2 GC For Intent-to-Treat Patients (ITT)
      3. 4.5.3 Prenatal and Preconception Care
      4. 4.5.4 Others
    6. 4.6 Industrial Automation & Equipment, BY Target Population Segment (USD Million)
      1. 4.6.1 General Population
      2. 4.6.2 Patient Population
    7. 4.7 Industrial Automation & Equipment, BY Level of Service (USD Million)
      1. 4.7.1 Pre-counseling Support
      2. 4.7.2 Post Counseling Support
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Industrial Automation & Equipment
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Industrial Automation & Equipment
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Myriad Genetics (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Invitae Corporation (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Ambry Genetics (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 GeneDx (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Fulgent Genetics (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 23andMe (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Color Genomics (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Natera (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY COUNSELING APPROACH
    3. 6.3 US MARKET ANALYSIS BY KEY PLAYERS BUSINESS MODEL
    4. 6.4 US MARKET ANALYSIS BY CHANNEL
    5. 6.5 US MARKET ANALYSIS BY TYPE OF SERVICE
    6. 6.6 US MARKET ANALYSIS BY APPLICATION
    7. 6.7 US MARKET ANALYSIS BY TARGET POPULATION SEGMENT
    8. 6.8 US MARKET ANALYSIS BY LEVEL OF SERVICE
    9. 6.9 KEY BUYING CRITERIA OF INDUSTRIAL AUTOMATION & EQUIPMENT
    10. 6.10 RESEARCH PROCESS OF MRFR
    11. 6.11 DRO ANALYSIS OF INDUSTRIAL AUTOMATION & EQUIPMENT
    12. 6.12 DRIVERS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
    13. 6.13 RESTRAINTS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
    14. 6.14 SUPPLY / VALUE CHAIN: INDUSTRIAL AUTOMATION & EQUIPMENT
    15. 6.15 INDUSTRIAL AUTOMATION & EQUIPMENT, BY COUNSELING APPROACH, 2024 (% SHARE)
    16. 6.16 INDUSTRIAL AUTOMATION & EQUIPMENT, BY COUNSELING APPROACH, 2024 TO 2035 (USD Million)
    17. 6.17 INDUSTRIAL AUTOMATION & EQUIPMENT, BY KEY PLAYERS BUSINESS MODEL, 2024 (% SHARE)
    18. 6.18 INDUSTRIAL AUTOMATION & EQUIPMENT, BY KEY PLAYERS BUSINESS MODEL, 2024 TO 2035 (USD Million)
    19. 6.19 INDUSTRIAL AUTOMATION & EQUIPMENT, BY CHANNEL, 2024 (% SHARE)
    20. 6.20 INDUSTRIAL AUTOMATION & EQUIPMENT, BY CHANNEL, 2024 TO 2035 (USD Million)
    21. 6.21 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TYPE OF SERVICE, 2024 (% SHARE)
    22. 6.22 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TYPE OF SERVICE, 2024 TO 2035 (USD Million)
    23. 6.23 INDUSTRIAL AUTOMATION & EQUIPMENT, BY APPLICATION, 2024 (% SHARE)
    24. 6.24 INDUSTRIAL AUTOMATION & EQUIPMENT, BY APPLICATION, 2024 TO 2035 (USD Million)
    25. 6.25 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TARGET POPULATION SEGMENT, 2024 (% SHARE)
    26. 6.26 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TARGET POPULATION SEGMENT, 2024 TO 2035 (USD Million)
    27. 6.27 INDUSTRIAL AUTOMATION & EQUIPMENT, BY LEVEL OF SERVICE, 2024 (% SHARE)
    28. 6.28 INDUSTRIAL AUTOMATION & EQUIPMENT, BY LEVEL OF SERVICE, 2024 TO 2035 (USD Million)
    29. 6.29 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY COUNSELING APPROACH, 2025-2035 (USD Million)
      2. 7.2.2 BY KEY PLAYERS BUSINESS MODEL, 2025-2035 (USD Million)
      3. 7.2.3 BY CHANNEL, 2025-2035 (USD Million)
      4. 7.2.4 BY TYPE OF SERVICE, 2025-2035 (USD Million)
      5. 7.2.5 BY APPLICATION, 2025-2035 (USD Million)
      6. 7.2.6 BY TARGET POPULATION SEGMENT, 2025-2035 (USD Million)
      7. 7.2.7 BY LEVEL OF SERVICE, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Genetic Counseling Market Segmentation

US Genetic Counseling Market By Counseling Approach (USD Million, 2025-2035)

  • Integrated
  • Independent
  • Discretionary Genetic Counseling

US Genetic Counseling Market By Key Players Business Model (USD Million, 2025-2035)

  • Core Genetic Counseling Companies
  • Direct-to-Consumer Genetic Testing Companies
  • Clinical Genetic Testing Companies

US Genetic Counseling Market By Channel (USD Million, 2025-2035)

  • Providers
  • Self-Referred Individuals

US Genetic Counseling Market By Type of Service (USD Million, 2025-2035)

  • Risk Assessment
  • Pharmacogenomics
  • Other Genetic Pediatric Care Counseling Services

US Genetic Counseling Market By Application (USD Million, 2025-2035)

  • Proactive Risk Assessment
  • GC For Intent-to-Treat Patients (ITT)
  • Prenatal and Preconception Care
  • Others

US Genetic Counseling Market By Target Population Segment (USD Million, 2025-2035)

  • General Population
  • Patient Population

US Genetic Counseling Market By Level of Service (USD Million, 2025-2035)

  • Pre-counseling Support
  • Post Counseling Support
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.